The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 

The new study, published in JAMA Cardiology, included data from more than 44,000 adults. 

The new device was designed to treat LAA occlusion or closure patients with atrial fibrillation who face a high risk of stroke.

Could the shift from treating a large base of cardiovascular patients proactively to a significantly smaller number reactively be the key to actually growing your healthcare business?

“Our results show that none of the athletes who underwent cardiac MRI had abnormal findings," one researcher explained. 

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  

The data will draw on everything from census findings to driving habits gathered from vehicle sensors to—arguably most consequentially—medical records.

The Medical Imaging Drugs Advisory Committee reviews data on radiopharmaceuticals and contrast media, recommending best practices to the agency's commissioner.